Kit ELISA Syndecan 1 sandwich (SDC1) (human): quantitative determination of Hu Syndecan 1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu Syndecan 1.
Accession number
P18827
Dose range
16.38-4000 pg/ml
Sensitivity of the dosage
14 pg/ml
Calibration range
14 pg/ml to 4000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA Syndecan 1 sandwich (SDC1) (human): quantitative determination of Hu Syndecan 1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu Syndecan 1.
Kit ELISA Syndecan 1 sandwich (SDC1) (human): quantitative determination of Hu Syndecan 1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu Syndecan 1.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
CD138 (Syndecane 1) is a transmembrane proteoglycan consisting of a nucleus protein and five glycosaminoglycans that can bind a variety of cytokines and modulate their activity and that of extracellular matrix components, but also influence many development processes. CD138 is primarily expressed in the differentiation of keratinocytes and is temporarily regulated upstream in all layers of the epidermis in the event of tissue damage. CD138 also expresses strongly on plasma cells and can be detected even on fibroblasts, vascular smooth muscle cells and endothelial cells. The upward and downward regulation of CD138 on the cell surface is often correlated with the gain in cancer characteristics. The serum levels of the past soluble sCD138 are used as a prognostic factor for carcinogenesis. CD138 should play a role in cell adhesion, cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins. In addition, CD138 is expressed on the surface of pre-B cells and plasma cells. However, it is absent from mature B cells and disappears from apoptotic myeloma cells. An altered CD138 expression was detected in several different tumour types. Although several transcription variants may exist for the CD138 gene, the full-length natures of only two variants have been described to date. These represent the main variants and code the same protein.